Moleculin Biotech (MBRX) Reports Q3 Loss of $0.12/Share

Moleculin Biotech (NASDAQ: MBRX) reported Q3 EPS of ($0.12), versus ($0.05) reported last year.

For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
• Jefferies names five top tech picks after August reporting season